• Legislation related to prescription drug prices, including the implementation of Inflation Reduction Act (IRA); access to epinephrine in schools and other community settings
• Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues
• Medical countermeasures research and development
• FAA reauthorization provisions related to emergency medicine.

Duration: September 13, 2013 to present

General Issues: Health Issues, Pharmacy, Defense, Budget/Appropriations, Aviation/Aircraft/Airlines, Economics/Economic Development, Taxation/Internal Revenue Code

Spending: about $1,220,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Federal Emergency Management Agency (FEMA), Federal Aviation Administration (FAA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS)